跳至主要内容
临床试验/EUCTR2016-000571-25-ES
EUCTR2016-000571-25-ES进行中(未招募)1 期

Seeking the ideal anti-hypertensive therapy in obesity-related hypertension. An open-label, single center, randomized clinical trial.

Fundació Clinic per a la Recerca Biomèdica0 个研究点开始时间: 2016年4月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • A. Age between 18 and 65.
  • B. grade II-III obesity
  • C. Moderate hypertension, with no end-organ affectation
  • D. Current treatment with less than 3 drugs.
  • E.normal renal function with GF (MDRD) > 60 ml/min.
  • F. Candidates to bariatric surgery.
  • G. written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A.Pregnant or lactating women
  • B.Fertile women not using a high effective contracepive method (in accordance with Clinical Trial Facilitation Group guidelines)
  • C. secondary hypertension
  • D. End-organ hypertension not allowing treatment discontinuation
  • E. Prior bariatric surgery
  • F. Any contraindication or intolerance to olmesartan, amlodipine or thiazides.

研究者

发起方
Fundació Clinic per a la Recerca Biomèdica

相似试验